Biomark Diagnostics Statistics

Total Valuation

CSE:BUX has a market cap or net worth of CAD 33.29 million. The enterprise value is 31.87 million.

Market Cap	33.29M
Enterprise Value	31.87M

Important Dates

The last earnings date was Friday, July 25, 2025.

Earnings Date	Jul 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	105.09M
Shares Outstanding	n/a
Shares Change (YoY)	+6.67%
Shares Change (QoQ)	-88.13%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	53.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	215.89
PB Ratio	19.12
P/TBV Ratio	19.12
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-16.54
EV / Sales	198.65
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-29.07

Financial Position

The company has a current ratio of 2.14, with a Debt / Equity ratio of 0.64.

Current Ratio	2.14
Quick Ratio	2.14
Debt / Equity	0.64
Debt / EBITDA	n/a
Debt / FCF	-1.02
Interest Coverage	-33.42

Financial Efficiency

Return on equity (ROE) is -340.71% and return on invested capital (ROIC) is -67.44%.

Return on Equity (ROE)	-340.71%
Return on Assets (ROA)	-60.59%
Return on Invested Capital (ROIC)	-67.44%
Return on Capital Employed (ROCE)	-107.65%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +61.36% in the last 52 weeks. The beta is -0.44, so CSE:BUX's price volatility has been lower than the market average.

Beta (5Y)	-0.44
52-Week Price Change	+61.36%
50-Day Moving Average	0.34
200-Day Moving Average	0.26
Relative Strength Index (RSI)	54.53
Average Volume (20 Days)	34,251

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CSE:BUX had revenue of CAD 154,216 and -1.93 million in losses. Loss per share was -0.02.

Revenue	154,216
Gross Profit	154,216
Operating Income	-2.05M
Pretax Income	-1.93M
Net Income	-1.93M
EBITDA	-2.03M
EBIT	-2.05M
Loss Per Share	-0.02

Full Income Statement

Balance Sheet

The company has 2.48 million in cash and 1.12 million in debt, giving a net cash position of 1.36 million.

Cash & Cash Equivalents	2.48M
Total Debt	1.12M
Net Cash	1.36M
Net Cash Per Share	n/a
Equity (Book Value)	1.74M
Book Value Per Share	0.02
Working Capital	1.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.09 million and capital expenditures -3,533, giving a free cash flow of -1.10 million.

Operating Cash Flow	-1.09M
Capital Expenditures	-3,533
Free Cash Flow	-1.10M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-1,327.45%
Pretax Margin	-1,249.73%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CSE:BUX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.67%
Shareholder Yield	n/a
Earnings Yield	-5.79%
FCF Yield	-3.29%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CSE:BUX has an Altman Z-Score of -0.68 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.68
Piotroski F-Score	2